Pharmacological Treatment of Tachyarrhythmias in Acute Myocardial Infarction - a Review

Deaconu, Alexandru; Deaconu, Silvia; Radu, Andrei; Dorobantu, Maria

doi:10.47803/rjc.2021.31.2.311

Abstract

Acute myocardial infarction (AMI) causes severe metabolic and electrophysiological changes that induce silent or symptomatic life-threatening arrhythmias. Ventricular arrhythmias and atrial fibrillation are common during the early phase of AMI and are also important prognostic factors. Rapid identification and treatment of these arrhythmias can be life-saving, since in-hospital mortality rises dramatically in patients who develop arrhythmias with a fast ventricular rate following an AMI. Along with myocardial revascularization, adequate pharmacological therapy of hemodynamically relevant arrhythmias is generally useful. Since there are no controlled randomized trials comparing different antiarrhythmic drugs (AADs) in AMI, optimal decision making is based on medical societies guidelines recommendations and clinical judgement.

References

B. Ibanez et al., “2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,” Eur. Heart J., vol. 39, no. 2, pp. 119–177, 2018, doi: 10.1093/eurheartj/ehx393.
Open DOI Search in Google Scholar Back to article
B. Gorenek et al., “Cardiac arrhythmias in acute coronary syndromes: Position paper from the joint EHRA, ACCA, and EAPCI task force,” Europace, 2014, doi: 10.1093/europace/euu208.
Open DOI Search in Google Scholar Back to article
J. Schmitt, G. Duray, B. J. Gersh, and S. H. Hohnloser, “Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications,” European Heart Journal. 2009, doi: 10.1093/eurheartj/ehn579.
Open DOI Search in Google Scholar Back to article
B. S. Crenshaw, S. R. Ward, C. B. Granger, A. L. Stebbins, E. J. Topol, and R. M. Califf, “Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience,” J. Am. Coll. Cardiol., vol. 30, no. 2, pp. 406–413, 1997, doi: 10.1016/S0735-1097(97)00194-0.
Open DOI Search in Google Scholar Back to article
S. R. Lee, E. K. Choi, K. Han, M. J. Cha, and S. Oh, “Prevalence of non-valvular atrial fibrillation based on geographical distribution and socioeconomic status in the entire Korean population,” Korean Circ. J., vol. 48, no. 7, pp. 622–634, 2018, doi: 10.4070/kcj.2017.0362.
Open DOI Search in Google Scholar Back to article
tefania Matei et al., “The Relationship Between Psychosocial Status and Hypertensive Condition.,” Curr. Hypertens. Rep., vol. 20, no. 12, p. 102, Oct. 2018, doi: 10.1007/s11906-018-0902-y.
Open DOI Search in Google Scholar Back to article
E. G. Daoud et al., “Effect of an irregular ventricular rhythm on cardiac output,” Am. J. Cardiol., 1996, doi: 10.1016/S0002-9149(97)89297-1.
Open DOI Search in Google Scholar Back to article
J. P. Piccini and L. A. Allen, “Heart Failure Complicated by Atrial Fibrillation: Don’t Bury the Beta-Blockers Just Yet,” JACC: Heart Failure. 2017, doi: 10.1016/j.jchf.2016.12.003.
Open DOI Search in Google Scholar Back to article
B. Gorenek and G. Kudaiberdieva, “Atrial Fibrillation in Acute St-Elevation Myocardial Infarction: Clinical and Prognostic Features,” Curr. Cardiol. Rev., 2012, doi: 10.2174/157340312803760857.
Open DOI Search in Google Scholar Back to article
Ş. Çelik, C. Erdöl, M. Baykan, Ş. Kaplan, and H. Kasap, “Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction,” Am. J. Cardiol., 2001, doi: 10.1016/S0002-9149(01)01611-3.
Open DOI Search in Google Scholar Back to article
G. Hindricks et al., “2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS),” Eur. Heart J., 2020, doi: 10.1093/eurheartj/ehaa612.
Open DOI Search in Google Scholar Back to article
Z. Kalarus et al., “Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: An European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and ,” Europace, 2019, doi: 10.1093/europace/euz163.
Open DOI Search in Google Scholar Back to article
C. T. January et al., “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation,” J. Am. Coll. Cardiol., 2019, doi: 10.1016/j.jacc.2019.01.011.
Open DOI Search in Google Scholar Back to article
J. B. Segal et al., “The evidence regarding the drugs used for ventricular rate control,” Journal of Family Practice. 2000.
Search in Google Scholar Back to article
M. Metawee et al., “Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial,” Int. J. Cardiol., 2016, doi: 10.1016/j.ijcard.2016.05.022.
Open DOI Search in Google Scholar Back to article
S. P. Thomas et al., “Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial,” Am. Heart J., 2004, doi: 10.1016/s0002-8703(03)00526-x.
Open DOI Search in Google Scholar Back to article
R. D. Lopes et al., “Digoxin and Mortality in Patients With Atrial Fibrillation,” J. Am. Coll. Cardiol., 2018, doi: 10.1016/j.jacc.2017.12.060.
Open DOI Search in Google Scholar Back to article
J.-P. Collet et al., “2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,” Eur. Heart J., pp. 1–79, 2020, doi: 10.1093/eurheartj/ehaa575.
Open DOI Search in Google Scholar Back to article
K. Saraf, P. Morris, P. Garg, P. Sheridan, and R. Storey, “Non-Vitamin K antagonist oral anticoagulants (NOACs): Clinical evidence and therapeutic considerations,” Postgrad. Med. J., vol. 90, no. 1067, pp. 520–528, 2014, doi: 10.1136/postgradmedj-2014-132605.
Open DOI Search in Google Scholar Back to article
C. P. Cannon et al., “Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation,” N. Engl. J. Med., 2017, doi: 10.1056/nejmoa1708454.
Open DOI Search in Google Scholar Back to article
C. M. Gibson et al., “Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI,” N. Engl. J. Med., 2016, doi: 10.1056/nejmoa1611594.
Open DOI Search in Google Scholar Back to article
R. D. Lopes et al., “Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation,” N. Engl. J. Med., 2019, doi: 10.1056/nejmoa1817083.
Open DOI Search in Google Scholar Back to article
P. Vranckx et al., “Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial,” Eur. Heart J., 2020, doi: 10.1093/eurheartj/ehaa617.
Open DOI Search in Google Scholar Back to article
F. J. Neumann et al., “2018 ESC/EACTS Guidelines on myocardial revascularization,” European Heart Journal. 2019, doi: 10.1093/eurheartj/ehy394.
Open DOI Search in Google Scholar Back to article
M. Eldar et al., “Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era,” Circulation, 1998, doi: 10.1161/01.CIR.97.10.965.
Open DOI Search in Google Scholar Back to article
O. D. Pedersen, H. Bagger, L. Køber, and C. Torp-Pedersen, “The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution.,” Eur. Heart J., 1999, doi: 10.1053/euhj.1998.1352.
Open DOI Search in Google Scholar Back to article
N. Danchin et al., “Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: Data from the FAST-MI register,” Heart, 2010, doi: 10.1136/hrt.2010.201574.
Open DOI Search in Google Scholar Back to article
R. D. Lopes et al., “Safety and Efficacy of Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials,” JAMA Cardiol., 2019, doi: 10.1001/jamacardio.2019.1880.
Open DOI Search in Google Scholar Back to article
D. E. Thomas, N. Jex, and A. R. Thornley, “Ventricular arrhythmias in acute coronary syndromes-mechanisms and management,” Contin. Cardiol. Educ., vol. 3, no. 1, pp. 22–29, 2017, doi: 10.1002/cce2.51.
Open DOI Search in Google Scholar Back to article
J. P. Piccini et al., “Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction,” Crit. Care Med., vol. 39, no. 1, pp. 78–83, 2011, doi: 10.1097/CCM.0b013e3181fd6ad7.
Open DOI Search in Google Scholar Back to article
M. J. Janse and A. L. Wit, “Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction,” Physiological Reviews. 1989, doi: 10.1152/physrev.1989.69.4.1049.
Open DOI Search in Google Scholar Back to article
M. Said et al., “Calcium-calmodulin dependent protein kinase II (CaMKII): A main signal responsible for early reperfusion arrhythmias,” J. Mol. Cell. Cardiol., 2011, doi: 10.1016/j.yjmcc.2011.08.010.
Open DOI Search in Google Scholar Back to article
J. M. Di Diego and C. Antzelevitch, “Ischemic ventricular arrhythmias: Experimental models and their clinical relevance,” Hear. Rhythm, 2011, doi: 10.1016/j.hrthm.2011.06.036.
Open DOI Search in Google Scholar Back to article
N. KH, T. T, Stebbins A, T. EJ, and Califf, “Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation nell’Infarto Miocardico (GISSI).,” Circulation, 1998.
Search in Google Scholar Back to article
V. Barletta, I. Fabiani, C. Lorenzo, I. Nicastro, and V. Di Bello, “Sudden cardiac death: A review focused on cardiovascular imaging,” Journal of Cardiovascular Echography. 2014, doi: 10.4103/2211-4122.135611.
Open DOI Search in Google Scholar Back to article
S. G. Priori et al., “2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Europea,” Eur. Heart J., vol. 36, no. 41, pp. 2793–2867l, 2015, doi: 10.1093/eurheartj/ehv316.
Open DOI Search in Google Scholar Back to article
C. J. Nalliah, S. Zaman, A. Narayan, J. Sullivan, and P. Kovoor, “Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias,” Europace, 2014, doi: 10.1093/europace/eut307.
Open DOI Search in Google Scholar Back to article
A. Volpi, A. Cavalli, L. Santoro, and E. Negri, “Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the gruppo italiano per lo studio della sopravvivenza nell’infarto miocardico (GISSI-2) database,” Am. J. Cardiol., 1998, doi: 10.1016/s0002-9149(98)00336-1.
Open DOI Search in Google Scholar Back to article
X. Z. He, S. H. Zhou, X. H. Wan, H. Y. Wang, Q. H. Zhong, and J. F. Xue, “The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome,” Clin. Cardiol., 2011, doi: 10.1002/clc.20818.
Open DOI Search in Google Scholar Back to article
R. Latini, A. P. Maggioni, M. Flather, P. Sleight, and G. Tognoni, “ACE inhibitor use in patients with myocardial infarction: Summary of evidence from clinical trials,” Circulation. 1995, doi: 10.1161/01.CIR.92.10.3132.
Open DOI Search in Google Scholar Back to article
J. S. Bundgaard et al., “Deep sedation as temporary bridge to definitive treatment of ventricular arrhythmia storm,” Eur. Hear. J. Acute Cardiovasc. Care, 2020, doi: 10.1177/2048872620903453.
Open DOI Search in Google Scholar Back to article
J. Bhar-Amato, W. Davies, and S. Agarwal, “Ventricular arrhythmia after acute myocardial infarction: ‘The perfect storm,’” Arrhythmia Electrophysiol. Rev., vol. 6, no. 3, pp. 134–139, 2017, doi: 10.15420/aer.2017.24.1.
Open DOI Search in Google Scholar Back to article
H. V. Huikuri, A. Castellanos, and R. J. Myerburg, “Sudden Death Due to Cardiac Arrhythmias,” N. Engl. J. Med., 2001, doi: 10.1056/nejmra000650.
Open DOI Search in Google Scholar Back to article
J. P. Piccini et al., “Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Re,” Am. J. Cardiol., vol. 102, no. 11, pp. 1427–1432, 2008, doi: 10.1016/j.amjcard.2008.07.033.
Open DOI Search in Google Scholar Back to article
H. J. Dargie, “Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial,” Lancet, 2001, doi: 10.1016/S0140-6736(00)04560-8.
Open DOI Search in Google Scholar Back to article
S. M. Al-Khatib et al., 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary, vol. 138, no. 13. 2018.
Search in Google Scholar Back to article
F. Mehraein, “A Review on Amiodarone as an Antiarrhythmic Drug,” Abnorm. Hear. Rhythm., 2015, doi: 10.5772/60418.
Open DOI Search in Google Scholar Back to article
R. M. L. Colunga Biancatelli, V. Congedo, L. Calvosa, M. Ciacciarelli, A. Polidoro, and L. Iuliano, “Adverse reactions of amiodarone,” J. Geriatr. Cardiol., vol. 16, no. 7, pp. 552–566, 2019, doi: 10.11909/j.issn.1671-5411.2019.07.004.
Open DOI Search in Google Scholar Back to article

Pharmacological Treatment of Tachyarrhythmias in Acute Myocardial Infarction - a Review

Abstract

Paradigm

My account